Article
Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 May 2015
Parkin Brian, Ouillette Peter, Yildiz Mehmet, Saiya-Cork Kamlai, Shedden Kerby, Malek Sami N
Abstract excerpt
PURPOSE: Recurrent gene mutations, chromosomal translocations, and acquired genomic copy number aberrations (aCNA) have been variously associated with acute myelogenous leukemia (AML) patient outcome. However, knowledge of the co-occurrence of such lesions and the relative influence of different types of genomic alterations on clinical outcomes in AML is still evolving. EXPERIMENTAL DESIGN: We performed SNP 6.0...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
